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Abstract
As potential agents for preventing different oxidative stress-related diseases, 
phenolic compounds have attracted increasing attention with the passage of 
time. Intake of fruits, vegetables and cereals in higher quantities is linked with 
decreased chances of chronic diseases. In plant-based foods, phenolic com-
pounds are very abundant. However, bio-accessibility and biotransformation of 
phenolic compound are not reviewed in these studies; therefore, a detailed action 
mechanism of phenolic compounds is not recognized. In this article, inclusive 
concept of different factors affecting the bioavailability of phenolic compounds 
and their metabolic processes is presented through which phenolic compounds 
go after ingestion.
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1. Introduction
In recent past, the awareness of the consumer related to the effect of diet 
on the health has been improved; therefore, leading to upsurge in the con-
sumption of vegetables, cereal based foods and fruits. Numerous studies have 
suggested the bioactive characteristics of the bioactive moieties, i.e., phenolic 
compounds. Nonetheless, bioactive claims are made without taking into consid-
eration the further modifications to which phenolic compounds are subjected 
once ingested [1].
Phenolic compounds are the secondary metabolites of plants which consti-
tute an important group, i.e., phenylpropanoids. These compounds possess an 
aromatic ring and various OH groups which are link to it. On the basis of clas-
sification, phenolic compounds are prorated into various subgroups. They are 
grouped as a function of the number of phenolic rings that they contain and the 
radicals that bind these rings to another one [2, 3]. Phenolic compounds have 
fetched substantial focus as the ingestion of these bioactive moieties is cor-
related to lower the prevalence of chronic ailments, for example, diabetes, CVD 
and cancer. Cereals, fruits, and vegetables are rich sources of phenolic com-
pounds. In fact, the health benefits of their dietary intake have been related, at 
least in part, to their phenolic compounds content [4]. This manuscript presents 
the bird’s eye view of the health claims as well as bioavailability of the phenolic 
compounds.
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2. Dietary phenolic compounds
Phenolic compounds are the derivatives of secondary metabolism of plants. 
Chemically phenolic compounds consist of aromatic ring to which one or more 
OH− substituents are attached [1, 5]. Despite of diversity of phenolic compounds, 
they are mainly divided into two subgroups, (1) flavonoids and (2) non-flavonoids. 
First one constitutes of heterocyclic oxygen which are bonded with two aromatic 
rings and depends on the amount of hydrogenation. They can be further subdivided 
into six subgroups, i.e., flavanol, flavones, anthocyanins, flavonols, flavanones 
and isoflavones. While the later one, like cinnamic and benzoic compounds, they 
contain aromatic ring which are attached to organic acids. Lignins, stilbenes and 
tannins are also the subgroups of non-flavonoid compounds. Characteristics like 
flavor, astringency and color are instigated due to presence of these compounds [1].
3. Food sources with reported bioactivity
Latterly, due to numerous health prompting effects, for example, antimicrobial 
[6], neuro-protective [7], antioxidant [8], cardioprotective [9], anti-inflammatory 
[10] and cancer preventive [11] properties, phenolic compounds have much of the 
attention of the researchers. Phenolic compounds possess different derivatives 
which have a potential application in the prevention or treatment of these aliments 
[12]. Likewise, Perez-Vizcaino et al. reported numerous studies which supports 
the fact that upsurge in the consumption of foods rich in the phenolic compounds 
might be linked with the prevention of above-mentioned disorders [13]. Vegetables, 
fruits and cereals have high concentration of the phenolics. Table 1 includes exam-
ples of some foods rich in phenolic compounds with reported biological effects.
4. Bioactivities of polyphenols
Since from the ancient times, bioactive moieties extracted from the natural 
sources have guarantee medicinal characteristics in combating against certain 
Phenolic compound Source References
Phenolic acids (gallic acid) Red wine [14]
Anthocyanins (cyanidin, delphinidin, 
malvidin, pelargonidin, peonidin)
Blackberry, blueberry, black grape, cherry, strawberry, 
red wine, plum
[15]
Condensed tannins (procyanidin) Red wine, chocolate, cranberry juice and apples [16]
Flavan-3-ols (catechin) Fruits, vegetables, chocolate, lentil, green and black tea, 
wine, grapes and ginkgo
[17, 18]
Flavanones (hespertin, naringenin) Orange, grapefruit and lemon juices [19]
Flavones (apigenin, luteolin) Parsley, celery, capsicum pepper and grape [18]
Flavonols (quercetin, kaempferol) Fruits, vegetables, and beverages such as tea and red 
wine
[20, 21]
Isoflavones (genistein) Soy [22]
Stilbenes (resveratrol) Legumes, grapes, red wine, soy, peanuts and peanut 
products
[23, 24]
Table 1. 
Phenolic compounds from food sources with reported biological effects.
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disorders [25]. These bioactive components have a wide range of potential applica-
tions, i.e., antimicrobial, antitumoral, antimicrobial, hepato-protection and anti-
oxidant. Few phenolic compounds show higher free radical scavenging properties 
individually, while numerous others showed these characteristics in synergism [26]. 
The free radical scavenging properties generally influenced by the chemical struc-
ture, position and number of OH− group as well as glycosylation or other forms 
of replacement [27]. Additionally, despite of nullification of the ROS, nitrosative 
and oxidative stress such as CVD, neurological disorders, diabetes mellitus, cancer, 
and hypertension have also been prevented by phenolic compounds [28]. Likewise, 
literature also showed the anti-inflammatory properties of the phenolic compounds 
[29]. It is observed during the inflammation several RNS (reactive nitrogen spe-
cies) as well as ROS (reactive oxygen species) are formed which escalate the action 
of proinflammatory factors. Phenolic compounds limit the pro-inflammatory 
enzymes thus prevent the human body from adverse effects [30].
In both developed and developing nations, cancer is the major cause of millions 
of demises each year [31]. For the treatment of numerous aliments, plants are the 
important ally in the traditional medicine. In pharmaceutical sector natural compo-
nents impart important proportion in the synthesis of new anticancer drugs [32]. In 
the treatment of tumor cell, the uses of synthetic moieties are linked with the toxicity 
problems. Carocho and Ferreira suggested that without any toxicity or side effects 
natural compounds extracted from plants can be administered. By using both human 
trial and in vivo models, the effects of phenolic compounds on tumor cells have been 
comprehensively investigated [26]. Huang et al. reported the capacity of phenolic 
compounds to induce apoptosis by regulate carcinogen metabolism, ontogenesis and 
cell cycle arrest, suppress cell adhesion and DNA binding, proliferation, migration 
and block signaling pathways [11]. Similarly, the effects of phenolic compounds 
against hepatoprotective capacity have also been comprehensively studied both in 
vitro and in vivo. Phenolic acid and flavonoids have fetched the attention due to high 
free radical scavenging properties which overcome liver injuries frequently caused 
due to oxidative reaction which endorse lipid peroxidation in hepatic tissues [33].
Beside above-mentioned bioactivities, polyphenols have exhibited numerous 
other health beneficial effects.
5. Bioavailability of phenolic compounds
It is necessary to have the knowledge about the availability of the bioactive 
component as they are very effect against in the prevention of the disorders. By 
definition, the concentration of nutrient that is ingested, absorbed and metabolized 
via normal passages [34]. The bioavailability profile is not directly improved by the 
intake of high content of phenolic compounds [35]. Rein and his fellows purposed 
that to guarantee the bio efficacy of phenolic compounds, bioavailability is recog-
nized as ultimate step, for example, at dietary level; the bioavailability is the pro-
portion of a food which is ingested and consumed and thus a matter of nutritional 
efficacy [36]. Hence, numerous other factors affected may impart interference in 
the direct bioavailability of the phenolic compounds present in the food. Examples 
of several external aspects are interaction with other moieties, food processing and 
various other intestinal factors [37]. Likewise, different and complex processes, 
i.e., distribution, liberation, elimination, absorption and metabolism phases also 
affect the bioavailability whereas, limiting factor, i.e., intestinal level absorption 
decreased the bioavailability [36].
Through the GIT tract, gallic acid and isoflavones which has small molecular 
weight are easily absorbed [35]. On the other hand, numerous phenolic compounds 
Plant Physiological Aspects of Phenolic Compounds
4
absorbed at a rate of 0.3–43% and the metabolite content circulating in the plasma 
can be low [36]. Likewise, kaempferol and quercetin belongs to flavonols exhibited 
several biological in vivo effects [38]. Yet, the utilization of these compounds as a 
potential health promoting components has inadequate efficiency due to the lessen 
bioavailability as a result of low absorption rate, low water solubility and increase 
instability in alkaline and neutral media including various organs, i.e., colon, small 
intestine, kidney and colon [39]. Due to low solubility and instability the use of 
apigenin is also limited in the pure form [40].
The bioavailability of phenolic compounds found in the foods begins in the oral 
cavity via metabolism reactions. In food transformation, mechanical action, i.e., 
mastication, impart significant role in the disruption of the food components which 
releases the compounds. In the oral cavity, the metabolism of glycosylated phenolic 
compounds commences immediately as the come in contact with the glycosidase 
enzymes of bacteria [41]. Literature showed that anthocyanin present in the fruit 
extract rich in phenolic compounds and human saliva, were moderately metabo-
lized by the oral microflora enzymes [42]. During the passage through the stomach, 
few compounds go through the hydrolysis while on the other hand numerous 
polyphenols remain intact. Correa-Betanzo and his fellows reported that stability 
and modification of these food components were interlinked with the reaction of 
intestinal microbiota. In the G.I tract, various phenolic components need structural 
modification for their absorption [43]. Few ex vivo studies indicated that phenolic 
acid absorption took place in intestinal portion, i.e., jejunum and colon or at the 
gastric level [44]. Certain chemical characteristics, for example, molecular weight, 
lipophilicity, stereochemistry and the presence of group capable of hydrogen 
bonding, affect the transport and permeability of the polyphenols into the cytosol 
enterocytes from the gut lumen [45]. It is believed that the phenolic compounds 
are absorbed by a passive diffusion mechanism or by carriers present in the intes-
tine, such as P-glycoprotein and cotransporters for SGLT1. These transporters are 
expressed on the cell membrane and transport the drugs into the cell interior [46, 47]. 
For example, aglycones cross the membrane of the epithelial cells via passive diffu-
sion [41], whereas on the other hand glycosides, esters and polymers cannot cross 
the membrane by passive diffusion.
As long as biotransformation reaction as concerned, liver is recognized as the 
main organ in which maximum glycosylated phenolic compounds are metabolized 
by the action of small intestinal microbiota enzymes as well as by the intestinal cell 
membrane hydrolases, i.e., lactase phlorizin hydrolase. These first passage reactions 
took place in the intestine, letting the prior metabolism of compounds, which, in 
turn, encourage absorption. From the colon these compounds are then transported 
to the liver through portal vein or distributed in the bloodstream by the plasma 
proteins. During the metabolism, variation in the concentration of substance in 
the blood is influenced by the structural changes and absorption. For instance, 
plasma protein, for example, albumin transports phenolic substances along with 
their metabolites [48]. Meanwhile in the liver, phenolic compounds are further 
bio- transformed which aim to make them more polar molecules, assisting in their 
excretion. In the liver, these biotransformation processes are mainly categorized 
into two phases, i.e., phase I includes oxidation and reduction, hydrolysis reactions 
which are catalyzed by the CYP450 enzymes [46], while phase II enhances the 
hydrophilicity of the molecules prior to their elimination [41].
5.1 Factors affecting the bioavailability
Variation in the phenolic bioavailability ranges from 0.3% in the case of antho-
cyanins to 43% estimated for isoflavones [49]. In this sense, Table 2 is imperative 
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to discuss that bioavailability is influenced by the food matrix and processing, 
phenolic structure and host; in addition to all these factors can interrelate with one 
another and effect bioavailability of the phenolic compounds, which make it tough 
to elaborate the particular mode of action of phenolic compounds. Additionally, 
pre-systemic elimination, release of a dosage form and absorption as well as route of 
administration also affects the bioavailability [58]. In order to elucidate the bioactive 
potential of phenolic compounds, in vivo estimation system is based on the inner 
wall as well as on the surface of the organs of the gastrointestinal tract, nonetheless 
such system did not reflect antioxidant in vivo effects [59], since solubility, base 
structure, interaction with other components as well as molecular size are the major 
physiochemical properties which lower the action of phenolic compounds [35].
6. Biotransformation of phenolic compounds
Transformation of lipophilic compounds into hydrophilic compounds is called 
biotransformation of heterologous compounds, in which the compounds are easily 
absorbed and excreted (Figure 1). The acetylation and methylation are excluded 
from this process, which reduces the water solubility of some alien organisms. 
Phenolic compounds are classified as exotic biological compounds which undertake 
heterologous biotransformation [61]. Heterogeneous biotransformation reactions can 
be divided into four categories, i.e., hydrolysis reaction, reduction reaction, oxidation 
reaction, and conjugation reaction. However, in study of dietary phenols, conjuga-
tion and oxidation are considered as most important reactions. Major sites of these 
reactions are cytoplasm, mitochondria, microsomes, and the tissues of the small 
intestine and liver [61]. Dietary phenolic compounds present in food have different 
structures as compared to those present in the tissues and peripheral circulation due 
to enduring metabolism after ingestion [62]. Phenol-sulfonate transferase, beta-
glucosidase, lactase root enzymes hydrolase, and UDP-glucuronyl transferase are 
the enzymes involved in these processes. Absorption and bioavailability of phenolic 
Type of factor References
Phenolics related 
factors
Chemical structure Chemical structure solubility bond with sugars 
(glycosides), methyl groups, etc. stereo-configuration.
[49]
Interaction with 
other compounds
Bonds with proteins (i.e., albumin) or with polyphenols 
with similar mechanism of absorption.
[50, 51]
Food related 
factors
Food processing Thermal treatments lyophilization cooking and 
methods of culinary preparation storage.
[52, 53]
Food interaction Food matrix presence of effectors of absorption 
(positive or negative) (i.e., fat, fiber).
[54]
Host related 
factors
Dietary intake Differences between countries and seasons quantity 
and frequency of exposure, single or multiple dose.
[55]
Absorption and 
metabolism
Intestinal factors (i.e., enzyme activity intestinal 
transit time colonic microflora). Systemic factors (i.e., 
gender and age disorders and/or pathologies genetics 
physiological condition).
[55]
Other factors Distribution and 
food content
Exclusivity in some foods (i.e., soy isoflavones, 
flavanones in citrus, etc.). Ubiquity (i.e., quercetin).
[56]
External factors Environmental factors (i.e., different stress conditions, 
degree of ripeness).
[57]
Table 2. 
Factors that can affect dietary phenolic compound bioavailability.
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compounds mostly depend on their metabolic reactions conducted in small intestine. 
In addition, those compounds which are not absorbed through stomach and small 
intestine are degraded in large intestine through colonic microorganisms [63].
However, during chewing and digestion inn stomach, the interactions struc-
tural characters of phenolic compounds can be modified with other food sub-
strates. This can decrease or increase small intestine’s biological accessibility [41]. 
These binding reactions produce metabolites that bind to albumin mainly through 
the blood and distributed to different tissues and organs. Phenolic compounds 
are metabolized by colonic bacteria in parts of the intestine that are not absorbed 
and reach the large intestine. Colonic bacteria destroy aromatic rings and release 
aglycones which can be absorbed when processed into derivatives of benzoic 
acid and combined with glucuronic acid, glycine and sulfate [64]. Conjugated 
hydroxycinnamic acid in vivo has an effect on their biological activity because 
antioxidant potential of hydroxycinnamic acid is determined through existence of 
free hydroxyl groups, which are the important spots of sulfation and glucuronida-
tion process [65].
7. Metabolism of phenolic compounds
7.1 Phase I
Biotransformation reactions involved during phase I of metabolism are oxida-
tion, reduction, and hydrolysis. The biological activity of phenolic compounds 
can be increased, decreased or counteracted through these reactions [61]. The first 
stage of the reaction aims to change the structure of exogenous biomolecules. This 
amendment is attained through introducing amino, carboxyl and hydroxyl groups, 
etc. The major purpose of this reaction is to enhance the polarity of heterogeneous 
phenolic compounds for facilitating their excretion [61].
7.1.1 Hydrolysis
Hydrolysis is mainly aimed at functional groups such as carboxylic esters, amides, 
and lactones. Carboxylesterases are the most important hydrolysis enzymes in 
Figure 1. 
Schematic representation of the metabolic pathway of phenols in humans after ingestion. Adapted from 
Grijalva et al. [60].
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mammals. However, aldehyde dehydrogenase, carbonic anhydrase, carboxypeptidase, 
lipase, and protease showed hydrolytic activity [61]. Lactose-phloretin hydrolase 
(LPH) exists in the human body. It mainly exists on one side of the small intestinal 
cavity. Lactose is hydrolyzed into galactose and glucose by LPH. It is also stated that 
flavonoid-O-beta-d-glycoside can be hydrolyzed through lactose-phloretin hydrolase 
resulting decrease of the polarity of the aglycones produced, thereby increasing the cell 
absorption of flavonoids [46]. However, the function of LPH can be disabled through 
stearic acid factor, and it cannot further hydrolyze glycosides (e.g., rhamnoside) [63].
7.1.2 Oxidation
During phase I of biotransformation, oxidation of phenolic compounds is the 
process having major importance. This reaction is primarily facilitated through 
enzyme-based oxidation process, controlled by CYP450 (microsomal cytochrome). 
CYP450 in humans has an extensive variety of substrates CYP3A4 (subfamily of 
CYP450) in gut is responsible for metabolic reactions of exogenous. According 
to different reports CYP3A4 interrelates with phenolic compounds. Therefore, 
it is suggested that some toxic consequences can be stimulated by the combined 
administration of both drugs and phenolic compounds [66]. Main factor affecting 
the metabolic activity of CYP450 regarding phenolic compounds include binding 
with different phenolic compounds, functional groups, glycosylation, molecular 
weight, polymerization and stereo-structure [5]. In addition, hydroxyl-rich flavo-
noids are unlikely to be processed through CYP450; unexpectedly, catechins from 
tea (hydroxyl-rich flavonoids) have been reported to inhibit CYP450 [67]. Still 
metabolic process of phenolic compounds is under research. Yet, the possible health 
potential of phenols has provoked further research in this area.
7.1.3 Reduction
Majority of the absorption of polyphenol took place in the large intestine where 
colonic microflora imparts significant role in the catabolism of these compounds. 
In humans, fission of the Cring both in naringenin and quercetin were done by the 
enzymes produced by the C. orbiscindens and E. ramulu, whereas E. casseliflavus 
were characterized for deglycosylation of Quercetin-1-glucode [68]. With the 
fission of Cring, epicatechin degradation initiated which lead to the synthesis of 
1-(3′,4′)-dihydroxyphenyl)-3-(2″,4″,6″-trihydroxy) propan-2-ol, which in turn 
transformed into 5-(3′,4′)-dihydroxyphenyl-valerolactone. Likewise, in the next step 
formation of 5-(3′,4′)-dihydroxyphenyl-valeric acid is done by the breakdown of 
valerolactone ring which further undergo beta oxidation to 3-hydroxyphenylpropi-
onic acid whereas if alpha oxidation is done, the resultant yield is 3-hydroxyphenyl-
acetic acid. Similarly, in epicatechin gallate and epigallocatechin gallate breakdown, 
the galloyl moiety is removed by the esterase enzyme and the released gallic acid is 
decarboxylated to pyrogallol [69]. In the liver, metabolites which are synthesize by 
the colon microglora are transformed to monosulfates of 5-(3′,4′)-dihydroxyphenyl-
valeric acid, hydroxyphenylpropionic acid and monoglucuronides through conjuga-
tion reactions. Afterword, majority of the metabolites are then transported in the 
blood stream and then eliminated from the body via urine [70], however the unab-
sorbed metabolites are excreted by the body with feces [71].
7.2 Phase II
The second stage of biotransformation involves the incorporation of different 
chemical radicals to exogenous compounds. In body transported free radicals are 
Plant Physiological Aspects of Phenolic Compounds
8
acquired from endogenous, polar, and highly available molecules. The major goal of 
this phase is to enhance the polarity of exogenous compounds. Increase in polarity is 
conducive to urination of exogenous substances [72]. Uridine 5′-diphosphate gluc-
uronide transferase, sulfonate transferase, and catechol O-methyltransferase are the 
related enzymes for metabolism of dietary polyphenol in second phase. The synthe-
sized molecule is bound to sulfate, glucuronic acid and/or methylation group [61]. 
Phenol conjugated compounds are different from their parent molecules regarding 
their ionic form, polarity and size. Thus, they are also different physiologically as 
compared to natural compounds. As a result, there is a growing need to know the 
possible health potential of these compounds either through in vitro studies.
7.2.1 Glucuronidation
It’s the major conjugation-based reaction in humans. Through using UDPGA 
(glucuronic acid diphosphate glucuronic acid) as a substrate, glucuronidation 
process binds to the exogenous compound like glucuronic acid. UDP glucose, UDP 
xylose, and UDP galactose can also be used as substrates for this reaction [61]. 
The enzyme responsible for catalyzing the process of glucuronidation is UDP-
glucuronide transferase. This enzyme exists in the microsomal tissue of the skin, 
brain, kidney, liver, and small intestine [73]. Glucuronidation sites are nucleophilic 
heteroatoms rich in electrons (like O, N or S). Thus, in glucuronidation reac-
tion mostly involved substrates comprise of functional groups, like phenols and 
aliphatic alcohols [74]. So, in human body metabolism glucuronidation is main 
binding reaction of phenolic compounds [75]. Steffen et al. reported the glucuronic 
acid metabolite (−)-epicatechin binding serum albumin is relatively less than its 
aglycone. Therefore, the absorption of intestinal cells can be enhanced by the activ-
ity of beta-glucuronidase or LPH. In addition, aglycones are more lipophilic than 
flavonoid glycosides, so they are more easily absorbed. In addition, it is of great 
significance to evaluate the glucuronidation process of phenolic acid and study its 
effects regarding bioavailability and biological activities [76].
7.2.2 Methylation
Epicatechin gallate and epicatechins are absorbed without hydrolysis or 
disruption of conjugated bonds [62]. Different research trials have revealed that 
about 50% of total epicatechin reaching the intestine is absorbed by metabolites 
(especially sulfate conjugates) that are cleared into the intestinal cavity, while the 
clearance of epicatechin is relatively mild. The (−)-epicatechin secreted by bile 
may also be absorbed and be cleared by efflux in another segment of the intestine 
[77]. As compared to conjugation process, methylation reaction differs because it 
normally reduces hydro solubility of phenolics and hides the functional groups to 
prevent them to be attacked by conjugating enzymes [61]. As mentioned earlier, 
flavonoids are mainly glucuronidation, however, methylation metabolites have also 
been detected, for example, O-methylation and glucuronidation have been found 
in perfusion studies of catechins or epicatechins. This reaction is supposed to be 
facilitated through enzyme COMT (catechol O-methyltransferase) [78].
The O-methyltransferase is a highly selective enzyme system in plants, micro-
organisms, and mammals. This enzyme is involved in O-methylation of flavonoids, 
which is a natural xenobiotic transformation [79]. Methylation of phenolic com-
pounds significantly improves their transportation through biological membranes 
and makes them more stable regarding metabolic reactions. It also improves their 
efficacy in different biological activities, especially their anti-tumor potential in 
cell culture research. Thus, as compared to hydroxylated derivatives in cell culture, 
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O-methylated flavonoids have a much better anticancer potential, due to being more 
resistant to metabolic reactions in liver and having high absorption in intestine [80]. 
In addition, methylated flavonoids play an important role in protein transportation 
having major role central role in the body defense system against toxic substances 
like MDR proteins [81]. It has been recommended that stability and transportation 
ability through biological membranes is improved by enhancing methylation degree 
and decreasing the number of free hydroxyl groups which can be bind with gluc-
uronic acid and sulfuric acid groups [82].
8. Applications in functional foods and nutraceutical formulations
Nowadays, some functional foods and health products can be found com-
mercially to capture consumers’ interests. The scientific community can prove the 
beneficial health effects of these products, and the food and pharmaceutical indus-
tries have followed suit to develop feasible production of novel high-yield products 
[83]. Medicinal and aromatic plants play an important role in the field because 
Phenolic 
compound
Source Application Bioactivity References
Antioxidant Antimicrobial
Phenolic acids Commercial Infant cereals ✓ _ [85]
Anthocyanins Cranberry (Vaccinium 
macrocarpon Ait.)
Nutraceutical 
capsules
✓ [86]
Phenolic 
extracts
Blackberry flower (Rubus 
ulmifolius Schott)
Yogurt ✓ _ [87]
Borage (Borago officinalis 
L.)
Fresh pasta _ ✓ [83]
Chamomile flower 
(Matricaria recutita L.)
Cottage cheese 
and yogurt
✓ ✓ [88, 89]
Fennel aerial parts 
(Foeniculum vulgare 
Mill.)
Cottage cheese 
and yogurt
✓ ✓ [88, 90]
Garcinia fruit (Garcinia 
cowa Roxb)
Bread ✓ _ [91]
Grape seed (Vitis vinífera 
L.)
Yogurt ✓ _ [92]
Green tea (Cammelia 
sinensis L.)
Bread ✓ _ [93]
Guava flower (Psidium 
guajava)
Bread melanoidins ✓ _ [94]
Pomegranate fruit 
(Punica granatum L.)
Yogurt and pasta ✓ _ [95, 96]
Pomegranate peels 
(Punica granatum L.)
Ice cream ✓ _ [97]
Rosemary (Rosmarinus 
officinalis L.)
Cottage cheese ✓ _ [98]
Veronicas (Veronica 
montana L.)
Cream cheese _ ✓ [99]
Table 3. 
Phenolic compounds used as nutraceuticals or bioactive compounds in functional foods.
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of their antioxidant, antimicrobial, and other beneficial effects in the prevention 
and treatment of certain diseases. The incorporation of these compounds in food 
can be carried out directly in free form; however, microencapsulation technology 
has emerged as a very effective and promising strategy to ensure the bioavail-
ability of these compounds and help overcome the problems of food processing 
and intake [84]. After ingestion, these compounds are absorbed into the blood, 
causing changes in various cellular mechanisms, thus preventing various diseases. 
Many kinds of literature have proved the biological activity of phenolic compounds 
in various plants and fruits, and few studies have reported its application in the 
development of functional food or nutritional preparations (Table 3).
9. Potential toxicity
In recent past years, the potential toxicity of some polyphenols, such as cat-
echins, to DNA of mouse spleen cells has been reported. DNA can be damaged due 
to high concentration of catechin on spleen cells of mice [100]. In addition, grape 
extract could also promote sister chromatid exchange induced by mitomycin C in 
human peripheral blood lymphocyte at a concentration of 75–300 μg/mL [101]. At 
the same concentration, the mixture of caffeic acid, gallic acid, and rutin hydrate 
could enhance mitomycin C induced fragmentation. In addition, after 24 h or 
more of high concentration epicatechin treatment, there was a significant negative 
effect on fibroblasts and keratinocytes. In addition, compounds with gallate groups 
showed more potential toxicity than compounds without gallate groups [102]. The 
results showed that polyphenols could play a positive role in the safe concentra-
tion range. However, polyphenol concentration is not the only determinant, and 
its negative effects are related to synergistic effects and exposure time. Therefore, 
the dosage and composition of polyphenols should be further studied for safe and 
healthy application [103].
10. Conclusion
Phenolic compounds, group of antioxidant phytochemicals have health promot-
ing effects and potential to decrease the chances of chronic diseases linked with 
high consumption of fruits, vegetables and cereals. Several epidemiological studies 
relate health promoting effects of plant-based foods to phenolic compounds. Still, 
there is a deficiency of studies and research work regarding metabolic pathway of 
these compounds; leading to a less understanding of their mechanism of action. 
Therefore, it’s essential to conduct further research to create improved approaches 
to take advantage of health promoting effects of these compounds.
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